Study design. Processing of patient samples (PB and BM) for MRD detection using different methods: CD34⁺/CD117⁺ DC analysis (A); and targeted error-reduced deep sequencing of known leukemia-specific molecular lesions in sorted CD34⁺/CD117⁺ cells (B); or in unsorted material (whole blood) (C).